Paper39025905
A robust cis-Mendelian randomization method with application to drug target discovery.
Lin Z and 1 other. Nat Commun, 2024. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. A robust cis-Mendelian randomization method with application to drug target discovery. Papers, record 39025905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39025905
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mendelian Randomization Analysis | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Linkage Disequilibrium | Major topic |
| Drug Discovery | Major topic |
| Humans | |
| Coronary Artery Disease | |
| Proprotein Convertase 9 | |
| Genetic Pleiotropy | |
| Genome-Wide Association Study | |
| Quantitative Trait Loci | |
| Likelihood Functions |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 AG073079 | NIA NIH HHS | United States | U01AG073079 | PubMed and NIH | NIH RePORTER |
| R01 AG074858 | NIA NIH HHS | United States | R01AG074858 | PubMed and NIH | NIH RePORTER |
| R01 AG065636, R01 AG069895, RF1 AG067924, U01 AG073079, R01 AG074858, R01 HL116720 and R01 GM126002 | U.S. Department of Health & Human Services | National Institutes of Health (NIH) | R01AG065636 | PubMed and NIH | NIH RePORTER | |
| R01 GM126002 | NIGMS NIH HHS | United States | R01GM126002 | PubMed and NIH | NIH RePORTER |
| R01 AG069895 | NIA NIH HHS | United States | R01AG069895 | PubMed and NIH | NIH RePORTER |
| R01 HL116720 | NHLBI NIH HHS | United States | R01HL116720 | PubMed and NIH | NIH RePORTER |
| RF1 AG067924 | NIA NIH HHS | United States | RF1AG067924 | PubMed and NIH | NIH RePORTER |
| R01 AG065636 | NIA NIH HHS | United States | R01AG065636 | PubMed and NIH | NIH RePORTER |
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27061298 | Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. | Genet Epidemiol | 2016 | https://conductscience.org/library/papers/27061298 | PubMed |
| 2 | 28527048 | Interpreting findings from Mendelian randomization using the MR-Egger method. | Eur J Epidemiol | 2017 | https://conductscience.org/library/papers/28527048 | PubMed |
| 3 | 35192729 | A two-sample robust Bayesian Mendelian Randomization method accounting for linkage disequilibrium and idiosyncratic pleiotropy with applications to the COVID-19 outcomes. | Genet Epidemiol | 2022 | https://conductscience.org/library/papers/35192729 | PubMed |
| 4 | 29040600 | Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. | Int J Epidemiol | 2017 | https://conductscience.org/library/papers/29040600 | PubMed |
| 5 | 24830394 | Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. | PLoS Genet | 2014 | https://conductscience.org/library/papers/24830394 | PubMed |
| 6 | 33004804 | Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids. | Nat Commun | 2020 | https://conductscience.org/library/papers/33004804 | PubMed |
| 7 | 25773378 | Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25773378 | PubMed |
| 8 | 31028273 | Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects. | Nat Commun | 2019 | https://conductscience.org/library/papers/31028273 | PubMed |
| 9 | 35507585 | A practical problem with Egger regression in Mendelian randomization. | PLoS Genet | 2022 | https://conductscience.org/library/papers/35507585 | PubMed |
| 10 | 28195242 | The alternative complement pathway is dysregulated in patients with chronic heart failure. | Sci Rep | 2017 | https://conductscience.org/library/papers/28195242 | PubMed |
| 11 | 36273411 | Statistical methods for cis-Mendelian randomization with two-sample summary-level data. | Genet Epidemiol | 2023 | https://conductscience.org/library/papers/36273411 | PubMed |
| 12 | 24114802 | Mendelian randomization analysis with multiple genetic variants using summarized data. | Genet Epidemiol | 2013 | https://conductscience.org/library/papers/24114802 | PubMed |
| 13 | 35615025 | Statistical methods for Mendelian randomization in genome-wide association studies: A review. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35615025 | PubMed |
| 14 | 27959767 | Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959767 | PubMed |
| 15 | 35235357 | Likelihood-based Mendelian randomization analysis with automated instrument selection and horizontal pleiotropic modeling. | Sci Adv | 2022 | https://conductscience.org/library/papers/35235357 | PubMed |
| 16 | 34214446 | Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. | Am J Hum Genet | 2021 | https://conductscience.org/library/papers/34214446 | PubMed |
| 17 | 36388766 | Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases. | Cell Genom | 2022 | https://conductscience.org/library/papers/36388766 | PubMed |
| 18 | 32591531 | Genetic drug target validation using Mendelian randomisation. | Nat Commun | 2020 | https://conductscience.org/library/papers/32591531 | PubMed |
| 19 | 37808547 | Causal Inference in Transcriptome-Wide Association Studies with Invalid Instruments and GWAS Summary Data. | J Am Stat Assoc | 2023 | https://conductscience.org/library/papers/37808547 | PubMed |
| 20 | 36948188 | Robust multivariable Mendelian randomization based on constrained maximum likelihood. | Am J Hum Genet | 2023 | https://conductscience.org/library/papers/36948188 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42977791 | From blood-expression signals to Kawasaki disease biomarkers: promise and limits of KLHL42 and SOS2. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42977791 | PubMed |
| 42964882 | Adiponectin and Pulmonary Hypertension Risk: Mendelian Randomization and Receptor-Side Genetic Evidence. | Pulm Circ | 2026 | https://conductscience.org/library/papers/42964882 | PubMed |
| 42877317 | Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42877317 | PubMed |
| 42842067 | GLP-1R expression and dermatological diseases: a mendelian randomization and real-world study. | Endocrine | 2026 | https://conductscience.org/library/papers/42842067 | PubMed |
| 42793049 | Pharmacology-Informed Human Genetic Evaluation of Panax notoginseng Saponin-Related Candidate Genes for Functional Outcome After Ischemic Stroke Using Mendelian Randomization and Colocalization. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42793049 | PubMed |
| 42784210 | From Proteomic Signatures to Candidate Endotypes in Obesity, Type 2 Diabetes, MASLD/MASH, and MetALD: Study Designs, Bioinformatics, and Biostatistical Strategies. | Proteomes | 2026 | https://conductscience.org/library/papers/42784210 | PubMed |
| 42704269 | TL-HDMR: a transfer learning framework for advancing equitable causal inference reveals metabolic signatures of stroke across multiple ancestries. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42704269 | PubMed |
| 42704268 | A flexible framework for robust and efficient Mendelian randomization with debiasing. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42704268 | PubMed |
| 42694095 | Shared Treg dysregulation underlies psoriasis vulgaris and atopic dermatitis through the PHF19-PRC2 epigenetic axis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42694095 | PubMed |
| 42682829 | Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42682829 | PubMed |
| 42502347 | Seipin as a Putative Protective Factor for Breast Cancer: Evidence from Mendelian Randomization Analysis. | Int J Womens Health | 2026 | https://conductscience.org/library/papers/42502347 | PubMed |
| 42465877 | Recalibrating Mendelian randomization under winner's curse, sample structure and polygenicity. | medRxiv | 2026 | https://conductscience.org/library/papers/42465877 | PubMed |
| 42332333 | Integration of transcriptome and mendelian randomization elucidates the protective role of aspirin in pulmonary tuberculosis development. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42332333 | PubMed |
| 42189912 | MR2G: A novel framework for causal network inference using GWAS summary data. | PLoS Genet | 2026 | https://conductscience.org/library/papers/42189912 | PubMed |
| 42177594 | Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis. | J Transl Med | 2026 | https://conductscience.org/library/papers/42177594 | PubMed |
| 42175412 | Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42175412 | PubMed |
| 42009889 | Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomization. | Nat Aging | 2026 | https://conductscience.org/library/papers/42009889 | PubMed |
| 41997142 | A flexible and unified framework for single- and multi-outcome Mendelian randomization using summary statistics. | Am J Hum Genet | 2026 | https://conductscience.org/library/papers/41997142 | PubMed |
| 41966688 | Integrating genetic data with biological insight: A practical guide to cis-Mendelian randomization. | Am J Hum Genet | 2026 | https://conductscience.org/library/papers/41966688 | PubMed |
| 41965819 | Epigenome-wide Mendelian randomization with multi-omics validation identifies epigenetic drivers of idiopathic pulmonary fibrosis. | Commun Biol | 2026 | https://conductscience.org/library/papers/41965819 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COLEC11 | 78989 | PubTator's text mining | https://conductscience.org/library/genes/78989 | NCBI Gene |
| FGFR1 | 2260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
| PCSK9 | 255738 | PubTator's text mining | https://conductscience.org/library/genes/255738 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39025905
GET https://conductscience.org/api/papers/v1/39025905/references?page=2